Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11548)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2017 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abdel-Rahman WM, Al-khayyal NA, Nair VA, Aravind SR, Saber-Ayad M. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations. World J Gastroenterol 2017; 23(19): 3440-3448 [PMID: PMC5442080 DOI: 10.3748/wjg.v23.i19.3440] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i19/3440.htm |
| Number | Citing Articles |
| 1 |
Vidhya A Nair, Noura A Al-khayyal, Sivaramakrishnan Sivaperumal, Wael M Abdel-Rahman. Calponin 3 promotes invasion and drug resistance of colon cancer cells. World Journal of Gastrointestinal Oncology 2019; 11(11): 971-982 doi: 10.4251/wjgo.v11.i11.971
|
| 2 |
Polona Safaric Tepes, Danilo Segovia, Sania Jevtic, Daniel Ramirez, Scott K. Lyons, Raffaella Sordella. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma. Laboratory Investigation 2022; 102(9): 1038 doi: 10.1038/s41374-021-00704-4
|
| 3 |
Yutao Liu, Xu Li, Shanling Jiang, Quanli Ge. Tetramethylpyrazine protects against high glucose-induced vascular smooth muscle cell injury through inhibiting the phosphorylation of JNK, p38MAPK, and ERK. Journal of International Medical Research 2018; 46(8): 3318 doi: 10.1177/0300060518781705
|
| 4 |
Lucia De Rosa, Rossella Di Stasi, Virginia Fusco, Luca D. D'Andrea. AXL receptor as an emerging molecular target in colorectal cancer. Drug Discovery Today 2024; 29(6): 104005 doi: 10.1016/j.drudis.2024.104005
|
| 5 |
Wei Song, Hao Wang, Minmin Lu, Xinxin Ni, Nacef Bahri, Shuihao Zhu, Limin Chen, Yuehong Wu, Jieqiong Qiu, Jonathan A. Fletcher, Wen-Bin Ou. AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression. Cancers 2020; 12(10): 2757 doi: 10.3390/cancers12102757
|
| 6 |
Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khorram, Reza Vafadar, Masoud Ghanaatian, Fatemeh Rezaei-Tazangi, Payam Baziyar, Amirhossein Ahmadi, Michael R. Hamblin, Amir Reza Aref. Receptor tyrosine kinase inhibitors in cancer. Cellular and Molecular Life Sciences 2023; 80(4) doi: 10.1007/s00018-023-04729-4
|
| 7 |
Olga L. Zinovieva, Evgenia N. Grineva, Maria M. Prokofjeva, Dmitry S. Karpov, Andrei O. Zheltukhin, George S. Krasnov, Anastasiya V. Snezhkina, Anna V. Kudryavtseva, Peter M. Chumakov, Tamara D. Mashkova, Vladimir S. Prassolov, Nikolai A. Lisitsyn. Expression of long non-coding RNA LINC00973 is consistently increased upon treatment of colon cancer cells with different chemotherapeutic drugs. Biochimie 2018; 151: 67 doi: 10.1016/j.biochi.2018.05.021
|
| 8 |
Mei Guo, Chengzhong You, Jun Dou. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates. Biomedicine & Pharmacotherapy 2018; 107: 1318 doi: 10.1016/j.biopha.2018.08.109
|
| 9 |
Shaimaa M.M. Bebars, Hala S.A. Mohammed, Ghada S. Osman, Mona A. Sakr. Immunohistochemical expression and prognostic value of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2/neu in primary colorectal carcinoma. Egyptian Journal of Pathology 2021; 41(1): 41 doi: 10.4103/egjp.egjp_30_21
|
| 10 |
Zihang Liu, Li Chen, Jifa Zhang, Jun Yang, Xue Xiao, Lianhai Shan, Wuyu Mao. Recent discovery and development of AXL inhibitors as antitumor agents. European Journal of Medicinal Chemistry 2024; 272: 116475 doi: 10.1016/j.ejmech.2024.116475
|
| 11 |
Dandan Xu, Deqiao Sun, Wei Wang, Xia Peng, Zhengsheng Zhan, Yinchun Ji, Yanyan Shen, Meiyu Geng, Jing Ai, Wenhu Duan. Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 2021; 220: 113497 doi: 10.1016/j.ejmech.2021.113497
|
| 12 |
Alya R. Alnuaimi, Justus Bottner, Vidhya A. Nair, Nival Ali, Razaz Alnakhli, Eva Dreyer, Iman M. Talaat, Hauke Busch, Sven Perner, Jutta Kirfel, Rifat Hamoudi, Wael M. Abdel-Rahman. Immunohistochemical Expression Analysis of Caldesmon Isoforms in Colorectal Carcinoma Reveals Interesting Correlations with Tumor Characteristics. International Journal of Molecular Sciences 2023; 24(3): 2275 doi: 10.3390/ijms24032275
|
| 13 |
Farheen Alam, Fatima Mezhal, Hussain EL Hasasna, Vidhya A Nair, SR Aravind, Maha Saber Ayad, Ahmed El-Serafi, Wael M Abdel-Rahman. The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells. Tumor Biology 2017; 39(9): 101042831771463 doi: 10.1177/1010428317714634
|
| 14 |
Alya R Alnuaimi, Vidhya A Nair, Lara J Bou Malhab, Eman Abu-Gharbieh, Anu Vinod Ranade, Gianfranco Pintus, Mohamad Hamad, Hauke Busch, Jutta Kirfel, Rifat Hamoudi, Wael M Abdel-Rahman. Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers. World Journal of Gastrointestinal Oncology 2022; 14(9): 1637-1653 doi: 10.4251/wjgo.v14.i9.1637
|
| 15 |
Yuan‐Lei Chen, Guang‐Ju Ge, Chao Qi, Huan Wang, Huai‐Lan Wang, Li‐Yang Li, Gong‐Hui Li, Li‐Qun Xia. A five‐gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma. Journal of Cellular Physiology 2018; 233(10): 6649 doi: 10.1002/jcp.26441
|
| 16 |
Pierluigi Rio, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci. Pollutants, microbiota and immune system: frenemies within the gut. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1285186
|
| 17 |
Shirin A. Hafezi, Wael M. Abdel-Rahman. The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy. Current Molecular Pharmacology 2019; 12(3): 230 doi: 10.2174/1874467212666190306164507
|
| 18 |
Jianhua Wu, Zhuchao Zhou. MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer. Clinical Breast Cancer 2021; 21(4): e462 doi: 10.1016/j.clbc.2021.01.014
|
| 19 |
Yohei Matsui, Tadaaki Yamada, Yuki Katayama, Soichi Hirai, Ryo Sawada, Yusuke Tachibana, Masaki Ishida, Hayato Kawachi, Ryota Nakamura, Naoya Nishioka, Kenji Morimoto, Masahiro Iwasaku, Mano Horinaka, Toshiyuki Sakai, Shinsaku Tokuda, Koichi Takayama. Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells. Cancer Science 2024; 115(10): 3333 doi: 10.1111/cas.16292
|
| 20 |
Vidhya A Nair, Satu Valo, Päivi Peltomäki, Khuloud Bajbouj, Wael M. Abdel-Rahman. Oncogenic Potential of Bisphenol A and Common Environmental Contaminants in Human Mammary Epithelial Cells. International Journal of Molecular Sciences 2020; 21(10): 3735 doi: 10.3390/ijms21103735
|
| 21 |
Daniel Ryan, Jim Koziol, Wael M. ElShamy. Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55702-w
|
| 22 |
Or-Yam Revach, Inna Grosheva, Benjamin Geiger. Biomechanical regulation of focal adhesion and invadopodia formation. Journal of Cell Science 2020; 133(20) doi: 10.1242/jcs.244848
|
| 23 |
Patricia F. de Souza Oliveira, Alessandra V. S. Faria, Stefano P. Clerici, Erica M. Akagi, Hernandes F. Carvalho, Giselle Z. Justo, Nelson Durán, Carmen V. Ferreira‐Halder. Violacein negatively modulates the colorectal cancer survival and epithelial–mesenchymal transition. Journal of Cellular Biochemistry 2022; 123(7): 1247 doi: 10.1002/jcb.30295
|